[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Report 2017

December 2017 | 114 pages | ID: A5B824400B0EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K MT), revenue (Million USD), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation for these regions, from 2012 to 2022 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers/players, with Oral Solid Dosage Pharmaceutical Formulation sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AstraZeneca Plc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • Gilead Sciences
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • AbbVie Inc.
  • Boehringer Ingelheim GmbH
  • Hoffman-La-Roche Ltd.
  • Johnson & Johnson
  • Biogen Inc.
  • Bayer AG
  • Teva Pharmaceticals
  • Amgen Inc.
  • Takeda Pharmaceutical Company Ltd.
  • Otsuka Pharmaceutical Co., Ltd.
  • Shire Plc.
  • Celgene Corporation
  • Astellas Pharma Inc.
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • By Form
    • Capsules
    • Powders
    • Tablets
  • By Drug Release Mechanism
    • Immediate Release
    • Extended Release
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospitals
  • Clinics
  • Other
If you have any special requirements, please let us know and we will offer you the report as you want.
Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Report 2017

1 ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION OVERVIEW

1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
1.2 Classification of Oral Solid Dosage Pharmaceutical Formulation by Product Category
  1.2.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Comparison by Types (2012-2022)
  1.2.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Capsules
  1.2.4 Powders
  1.2.5 Tablets
1.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market by Application/End Users
  1.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales (Volume) and Market Share Comparison by Applications (2012-2022)
  1.3.2 Hospitals
  1.3.3 Clinics
  1.3.4 Other
1.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market by Region
  1.4.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 China Status and Prospect (2012-2022)
  1.4.3 Japan Status and Prospect (2012-2022)
  1.4.4 South Korea Status and Prospect (2012-2022)
  1.4.5 Taiwan Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
  1.4.7 Southeast Asia Status and Prospect (2012-2022)
  1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Oral Solid Dosage Pharmaceutical Formulation (2012-2022)
  1.5.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Growth Rate (2012-2022)
  1.5.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2022)

2 ASIA-PACIFIC ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
  2.1.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Type
  2.2.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2012-2017)
  2.2.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation (Volume) by Application
2.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation (Volume and Value) by Region
  2.4.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Region (2012-2017)
  2.4.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Region (2012-2017)

3 CHINA ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

3.1 China Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  3.1.1 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  3.1.2 China Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  3.1.3 China Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
3.2 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
3.3 China Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

4 JAPAN ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  4.1.1 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  4.1.2 Japan Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  4.1.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
4.2 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
4.3 Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

5 SOUTH KOREA ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  5.1.1 South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  5.1.2 South Korea Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  5.1.3 South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
5.2 South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
5.3 South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

6 TAIWAN ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  6.1.1 Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  6.1.2 Taiwan Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  6.1.3 Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
6.2 Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
6.3 Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

7 INDIA ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

7.1 India Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  7.1.1 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  7.1.2 India Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  7.1.3 India Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
7.2 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
7.3 India Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

8 SOUTHEAST ASIA ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  8.1.1 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  8.1.2 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  8.1.3 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
8.2 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
8.3 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

9 AUSTRALIA ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Oral Solid Dosage Pharmaceutical Formulation Sales and Value (2012-2017)
  9.1.1 Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate (2012-2017)
  9.1.2 Australia Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate (2012-2017)
  9.1.3 Australia Oral Solid Dosage Pharmaceutical Formulation Sales Price Trend (2012-2017)
9.2 Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Type
9.3 Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Market Share by Application

10 ASIA-PACIFIC ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 AstraZeneca Plc.
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Main Business/Business Overview
10.2 Bristol-Myers Squibb Company
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Main Business/Business Overview
10.3 Eli Lilly and Company
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Main Business/Business Overview
10.4 Gilead Sciences
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Main Business/Business Overview
10.5 Merck & Co. Inc.
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Main Business/Business Overview
10.6 Novartis AG
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Main Business/Business Overview
10.7 Pfizer Inc.
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Main Business/Business Overview
10.8 AbbVie Inc.
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Main Business/Business Overview
10.9 Boehringer Ingelheim GmbH
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Main Business/Business Overview
10.10 Hoffman-La-Roche Ltd.
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue, Price and Gross Margin (2012-2017)
  10.10.4 Main Business/Business Overview
10.11 Johnson & Johnson
10.12 Biogen Inc.
10.13 Bayer AG
10.14 Teva Pharmaceticals
10.15 Amgen Inc.
10.16 Takeda Pharmaceutical Company Ltd.
10.17 Otsuka Pharmaceutical Co., Ltd.
10.18 Shire Plc.
10.19 Celgene Corporation
10.20 Astellas Pharma Inc.

11 ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MANUFACTURING COST ANALYSIS

11.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC ORAL SOLID DOSAGE PHARMACEUTICAL FORMULATION MARKET FORECAST (2017-2022)

15.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Price Forecast (2017-2022)
  15.1.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate Forecast (2017-2022)
  15.1.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast (2017-2022)
  15.1.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume and Growth Rate Forecast by Region (2017-2022)
  15.2.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast by Region (2017-2022)
  15.2.3 China Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.4 Japan Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.5 South Korea Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.6 Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.7 India Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.8 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
  15.2.9 Australia Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales, Revenue and Price Forecast by Type (2017-2022)
  15.3.1 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Type (2017-2022)
  15.3.2 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Forecast by Type (2017-2022)
  15.3.3 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Price Forecast by Type (2017-2022)
15.4 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Forecast by Application (2017-2022)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Solid Dosage Pharmaceutical Formulation
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsules Product Picture
Figure Powders Product Picture
Figure Tablets Product Picture
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) by Application (2012-2022)
Figure Asia-Pacific Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Other Examples
Table Key Downstream Customer in Other
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Size (Million USD) by Region (2012-2022)
Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate (2012-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Major Players Product Sales Volume (K MT)(2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) of Key Players/Suppliers (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Share by Players/Suppliers
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Market Major Players Product Revenue (Million USD) 2012-2017
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) by Players/Suppliers (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players
Figure 2017 Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Players
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales and Market Share by Type (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type (2012-2017)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Growth Rate by Type (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Type (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Type (2012-2017)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Growth Rate by Type (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Market Share by Region (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Region in 2016
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Market Share by Region (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Share (%) by Region (2012-2017)
Figure Revenue Market Share of Oral Solid Dosage Pharmaceutical Formulation by Region (2012-2017)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share by Region in 2016
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Market Share by Application (2012-2017)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Share (%) by Application (2012-2017)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share by Application (2012-2017)
Figure China Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Applications (2012-2017)
Table China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure China Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Applications (2012-2017)
Table Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Applications (2012-2017)
Table South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Applications (2012-2017)
Table Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Figure India Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Application (2012-2017)
Table India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure India Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Applications (2012-2017)
Table Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate (2012-2017)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Sales Price (USD/MT) Trend (2012-2017)
Table Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Type (2012-2017)
Table Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type (2012-2017)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Type in 2016
Table Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) by Applications (2012-2017)
Table Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application (2012-2017)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share by Application in 2016
Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Novartis AG Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate (2012-2017)
Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Sales Market Share in Asia-Pacific (2012-2017)
Figure Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share in Asia-Pacific (2012-2017)
Table Johnson & Johnson Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Biogen Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Bayer AG Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Teva Pharmaceticals Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Amgen Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Takeda Pharmaceutical Company Ltd. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Otsuka Pharmaceutical Co., Ltd. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Shire Plc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Celgene Corporation Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Astellas Pharma Inc. Oral Solid Dosage Pharmaceutical Formulation Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/MT) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Solid Dosage Pharmaceutical Formulation
Figure Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation
Figure Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
Table Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2016
Table Major Buyers of Oral Solid Dosage Pharmaceutical Formulation
Table Distributors/Traders List
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) and Trend Forecast (2017-2022)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume (K MT) Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Volume Market Share Forecast by Region in 2022
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Region (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Region in 2022
Figure China Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure China Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Japan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure South Korea Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Taiwan Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure India Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure India Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure Australia Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Type (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue (Million USD) Forecast by Type (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Revenue Market Share Forecast by Type (2017-2022)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Price (USD/MT) Forecast by Type (2017-2022)
Table Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales (K MT) Forecast by Application (2017-2022)
Figure Asia-Pacific Oral Solid Dosage Pharmaceutical Formulation Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories